Skip to main content
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. logo

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — Investor Relations & Filings

Ticker · 2196 HKEX Manufacturing
Open in API
Filings indexed 4,426 across all filing types
Latest filing 2026-04-10 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2196

About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

http://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven healthcare industry group operating across pharmaceuticals, medical devices, medical diagnosis, and healthcare services. The company focuses on therapeutic areas including oncology, cardiovascular, central nervous system, and metabolism, prioritizing technological advancement in small molecule development, antibody/ADC platforms, and cell therapies. Key products include Yikeda®, China's first approved CAR-T cell therapy product, and innovative biologics such as the anti-PD-1 monoclonal antibody Hanszhuang®. Fosun Pharma is a significant global health contributor via Artesun® (Artesunate injection), a WHO-recommended first-line treatment for severe malaria. The company also markets biosimilars, including Hanquyou® (Trastuzumab), which achieved dual approval in China and Europe, and distributes high-value medical devices, such as the Da Vinci surgical robot.

Recent filings

Filing Released Lang Actions
Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Subsidiary
Regulatory Filings Classification · 1% confidence The document is a regulatory announcement under HKEX Listing Rule 13.10B, providing details of a drug registration approval for a subsidiary. It is not a financial report, dividend notice, capital change, or management presentation but a general regulatory disclosure. It does not fit any more specific category, so it belongs in Regulatory Filings (RNS).
2026-04-10 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The document is extremely short (under 5,000 characters) and simply states that an announcement has been published in another section of the website. It does not contain any substantive financial or operational details itself, but merely notifies readers that a report is available elsewhere. This matches the definition of a Report Publication Announcement (RPA).
2026-04-10 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 1% confidence The document is an announcement of the date for the board meeting to consider and approve quarterly results. It contains no financial figures, no changes in management, and is not the report itself nor an earnings release. There is no specific category for a board‐meeting notice, so it defaults to a general regulatory filing (RNS).
2026-04-10 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The document is extremely brief (only an announcement stating that an issuer has published an announcement in another section), with no substantive financial or management content. It explicitly states that a report/announcement has just been published rather than containing the report itself. This aligns with a Report Publication Announcement (RPA).
2026-04-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The document is extremely short (under 5,000 characters) and merely states that an announcement has been published in the Chinese section of the website. It does not contain substantive report content, financial data, or details of corporate actions. This fits the definition of a Report Publication Announcement (RPA) rather than the report itself.
2026-04-02 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The text is extremely short (242 characters) and simply states that an announcement has been published on the website, without providing any substantive report or content itself. This clearly fits the ‘Report Publication Announcement’ category rather than a full report or regulatory filing.
2026-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.